V Knott
Overview
Explore the profile of V Knott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weller D, MacKenzie J, Knott V
Eur J Cancer Care (Engl)
. 2017 Jan;
26(1).
PMID: 28111854
No abstract available.
2.
Knott V, Weller D
Eur J Cancer Care (Engl)
. 2016 Feb;
25(2):205-7.
PMID: 26918682
No abstract available.
3.
Bowers H, Smith D, de la Salle S, Choueiry J, Impey D, Philippe T, et al.
Genes Brain Behav
. 2015 Jun;
14(6):466-76.
PMID: 26096691
Performance improvements in cognitive tasks requiring executive functions are evident with nicotinic acetylcholine receptor (nAChR) agonists, and activation of the underlying neural circuitry supporting these cognitive effects is thought to...
4.
Skaczkowski G, Hayman T, Strelan P, Miller J, Knott V
Eur J Cancer Care (Engl)
. 2013 Jun;
22(4):474-83.
PMID: 23730795
Many users of Complementary and Alternative Medicines (CAMs) claim that participation leads to improved well-being; however, contradictory evidence exists, with some studies linking CAM use with poorer quality of life...
5.
de la Salle S, Smith D, Choueiry J, Impey D, Philippe T, Dort H, et al.
Neuroscience
. 2013 Mar;
241:147-56.
PMID: 23535252
Elevated smoking rates seen in schizophrenia populations may be an attempt to correct neuropathologies associated with deficient nicotinic acetylcholine receptors and/or dopaminergic systems using exogenous nicotine. However, nicotine's effects on...
6.
Connerty T, Knott V
Eur J Cancer Care (Engl)
. 2013 Jan;
22(3):334-44.
PMID: 23301508
The increasing population of cancer survivors underscores the need to develop a complete understanding of the survivorship experience, including positive aspects. The aim of this study was to explore people's...
7.
Beatty L, Koczwara B, Knott V, Wade T
Eur J Cancer Care (Engl)
. 2011 Aug;
21(1):98-106.
PMID: 21848581
While 50% of cancer patients use complementary therapies (CT) during treatment, few studies have examined why individuals choose not to use CT. This study aimed to address this gap in...
8.
Millar A, Smith D, Choueiry J, Fisher D, Albert P, Knott V
Neuroscience
. 2011 Feb;
180:148-56.
PMID: 21315807
Although schizophrenia has been considered primarily a disease of dopaminergic neurotransmission, the role of dopamine in auditory sensory gating deficits in this disorder and their amelioration by smoking/nicotine is unclear....
9.
Knott V, Millar A, Fisher D, Albert P
Neuroscience
. 2009 Dec;
166(1):145-56.
PMID: 19961902
Evidence of normalized auditory P50 suppression with acute nicotine in schizophrenia has supported the contention that elevated smoking rates in this disorder may be an attempt to correct a nicotinic...
10.
Knott V, McIntosh J, Millar A, Fisher D, Villeneuve C, Ilivitsky V, et al.
Pharmacol Biochem Behav
. 2006 Oct;
85(1):228-42.
PMID: 17023037
As the increased smoking prevalence in schizophrenics may be interpreted as an adaptive response to an underlying biological defect, investigations into nicotine's actions within N-methyl-d-aspartate (NMDA) antagonist drug models of...